Abstract
Introduction
Extranodal non-Hodgkin lymphoma (NHL) were commonly described in AIDS patients and are related with an atypical morphology and aggressive clinical course.
Materials and Methods
In this single institutional study we evaluated the epidemiological, clinical, immunological, virological, histopathological and the outcome of eleven HIV/AIDS patients with oral cavity lymphomas (OCL).
Results
Nine were males and seven intravenous drug abusers. The median of age was 33 years and the median of CD4 T cell counts at the time of diagnosis was 97 cell/µL. The majority of tumors presented as large and ulcerated masses involving the gingiva, the palate and the jaw. Six of these tumors were diffuse large B-cell lymphomas (DLBCL); three were Burkitt’s lymphomas and the final case was a plasmablastic lymphoma. An association with Epstein-Barr virus (EBV) was found in three of the ten tested cases by in situ hybridization (EBER 1 and 2 probes) and immunohistochemistry (LMP-1). Human herpes virus-8 (HHV-8) was detected by polymerase chain reaction (PCR) in only one neoplasm. Six patients died without specific treatment; four received chemotherapy and highly active antiretroviral therapy (HAART) and three of them presented a prolonged survival.
Discussion
Combination of HAART and chemotherapy should modify the poor prognosis of AIDS patients with OCL.
Similar content being viewed by others
References
Wolf T, Brodt H-R, Fichtlscherer S, Mantzsch K, Hoelzer D, Helm EB, et al. Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin’s lymphoma in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma. 2005;46:207–15.
Tirelli U, Spina M, Gaidano G, Vaccer E, Franceschi S, Carbone A. Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy. AIDS. 2000;14:1675–88.
Cattaneo C, Facchetti F, Re A, Borlenghi E, Majorana A, Bardellini E, et al. Oral cavity lymphomas in immunocompetent and human immunodeficiency virus infected patients. Leuk Lymphoma. 2005;46:77–81.
Corti M, Solari R, Cangelosi D, De Carolis L, Schtirbu R, Lewi D. Oral cavity lymphoma as second AIDS-defining neoplasm in a patient with HAART and immune reconstitution. Rev Soc Bras Med Trop. 2007;40:1–35.
Jaffe ES, Harris NL, Stein H, Vardiman Jwe. Pathology and genetics of tumors of haemopoietic and lymphoid tissues. Lyon: IARC Press. 2001
Levine AM, Seneviratne L, Espina BM, Wohl AR, Tulpule A, Nathwani BN, et al. Evolving characteristic of AIDS-related lymphoma. Blood. 2000;96:4084–90.
Jordan RCK, Speight PM. Extranodal non-Hodgkin's lymphomas of the oral cavity. Curr Top Pathol. 1996;90:125–6.
Otter R, Gerrits WBJ, van der Sandt MM, Hermans J, Willemze R. Primary extranodal and nodal non-Hodgkin's lymphoma. Eur J Cancer Clin Oncol. 1989;25:1203–10.
Porter SR, Diz Dios P, Kumar N, Stock C, Barret AW, Scully C. Oral plasmablastic lymphoma in previously undiagnosed HIV disease. Oral Surg Oral Med Oral Pathol. 1999;87:730–4.
Corti M, Villafañe MF, Cermelj M, Candela M, Pérez Bianco R, Tezanos Pinto M. Cavum lymphoma in a haemophilic patient with AIDS. Medicina (Buenos Aires). 2000;60:351–3.
Cioc AM, Allen C, Kalmar JR, Suster S, Baiocchi R, Nuovo GJ. Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol. 2004;28:41–6.
Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U, et al. Plasmablastic lymphoma of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;89:1413–20.
Flaitz CM, Nichols CM, Walling DM, Hicks MJ. Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations. Oral Oncol. 2002;38:96–102.
Calzolari A, Papucci A, Baroni G, Ficarra G, Porfirio B, Chiarelli I, et al. Epstein-Barr virus infection and p53 expression in HIV-related oral large B-cell lymphoma. Head Neck. 1999;21:454–60.
Durberg AS, Nordstrom M, Torner A, Reichard O, Strauss R, Janzon R, et al. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology. 2005;4:652–9.
Brown RSD, Power DA, Spittle HF, Lankester KJ, et al. Abscence of immunohistochemical evidence for human herpesvirus 8 in oral cavity plasmablastic lymphoma in an HIV-positive man. Clin Oncol. 2000;12:194–6.
Nasta SD, Carrum GM, Shahab I, Hanania NA, Udden MM. Regression of plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma. 2002;43:423–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Corti, M., Villafañe, M.F., Solari, R. et al. Non-Hodgkin Lymphomas of the Oral Cavity in AIDS Patients in a Reference Hospital of Infectious Diseases in Argentina: Report of Eleven Cases and Review of the Literature. J Gastrointest Canc 42, 143–148 (2011). https://doi.org/10.1007/s12029-010-9173-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-010-9173-9